Coskun et al., 'LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept', Cell Metab
It means physician supervision, appropriate patient selection, and honest conversations about what the evidence does and doesn't support
However, rigorous clinical investigations are still needed to translate these promising findings with molecular hydrogen to human wound healing
doi: 10.1016/j.focha.2023.100539 6
"GLP-1 Receptor Agonists and Risk of Gallbladder Disease." Diabetes Care, 2020.Egan A.G., et al
Your metabolism gets what it needs to get better energy from what you eat